Objective: This study was designed to identify the 58-kDa inner ear protein
against which the sera of some patients with idiopathic, progressive senso
rineural hearing loss or Meniere's disease strongly react.
Background: We and other groups have previously demonstrated that a 58-kDa
protein extracted from guinea pig or bovine inner ear tissue is a target of
antibodies in serum samples from some patients with autoimmune inner ear d
iseases.
Methods: After separation of inner ear proteins by 10% sodium dodecyl sulfa
te polyacrylamide gel electrophoresis, the bands corresponding to 58 kDa we
re localized and excised from the gel. The concentrated protein was then di
gested with trypsin, and the peptide fragments were separated by high-press
ure liquid chromatography. Three fractions were subjected to amino acid seq
uencing by the classic Edman degradation.
Results: The sequence of a stretch of 14 amino acids of the first fragment
was identical to that of amino acids 526 to 539 of the COCH5B2 protein. The
sequences of 11 and 10 amino acids of the second and third fragments, resp
ectively, also were identical to residues 417 to 427 and 396 to 405 of the
COCH5B2 protein. These data, together with two-dimensional gel electrophore
sis followed by Western blot experiments, confirmed that the 58-kDa inner e
ar protein is the COCH5B2 protein.
Discussion: These findings indicate that the 58-kDa target protein of antib
odies in serum samples of patients with autoimmune inner ear diseases is th
e COCH5B2 protein, a molecule that is highly and specifically expressed in
the cochlea and vestibule.